Expression of GAD65 and islet cell antibody (ICA512) autoantibodies among cytoplasmic ICA+ relatives is associated with eligibility for the Diabetes Prevention Trial-Type 1. (Q43687828)
Jump to navigation
Jump to search
scientific article published in August 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Expression of GAD65 and islet cell antibody (ICA512) autoantibodies among cytoplasmic ICA+ relatives is associated with eligibility for the Diabetes Prevention Trial-Type 1. |
scientific article published in August 2001 |
Statements
1 reference
Expression of GAD65 and islet cell antibody (ICA512) autoantibodies among cytoplasmic ICA+ relatives is associated with eligibility for the Diabetes Prevention Trial-Type 1. (English)
1 reference
G S Eisenbarth
1 reference
J P Krischer
1 reference
N Maclaren
1 reference
J P Palmer
1 reference
L Yu
1 reference
D D Cuthbertson
1 reference
R Jackson
1 reference
T Orban
1 reference
DPT-1 Participating Investigators
1 reference
1 August 2001
1 reference
Identifiers
1 reference